Publications
Academic article
- Øivind Torkildsen; Hilde Kjelgaard Brustad; Einar August Høgestøl et al. (2026). Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis. (external link)
- Andrea Kyvik Habbestad; Johannes Sverre Willumsen; Jan Harald Aarseth et al. (2023). Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study. (external link)